ID Chief @ UMich
@adamlauring.bsky.social
Account of Adam Lauring, MD, PhD. Professor and Chief of Infectious Diseases at the University of Michigan. News and tidbits from the Division and about ID. Opinions my own.
Reposted by ID Chief @ UMich
I don’t know if anyone else notices or cares, but when I see a presentation in which the speaker uses obviously generated-AI images to illustrate their slides, it makes me immediately less confident in whatever other content they’re presenting.
November 28, 2025 at 3:07 PM
I don’t know if anyone else notices or cares, but when I see a presentation in which the speaker uses obviously generated-AI images to illustrate their slides, it makes me immediately less confident in whatever other content they’re presenting.
We're hiring! Clinical Assistant Professor in Infectious Diseases. Great group of physicians and great community!
November 19, 2025 at 3:47 PM
We're hiring! Clinical Assistant Professor in Infectious Diseases. Great group of physicians and great community!
Reposted by ID Chief @ UMich
This only happens to you once
September 26, 2025 at 7:39 PM
This only happens to you once
Wow, it's been a while since I've had to prepare a powerpoint in 4:3 aspect ratio!
September 8, 2025 at 8:22 PM
Wow, it's been a while since I've had to prepare a powerpoint in 4:3 aspect ratio!
Reposted by ID Chief @ UMich
A bizarre dogma has emerged among the anti-mRNA crowd that the only data we have on vaccines is from the original trial papers, rather than the HUGE volume of studies that came out subsequently...
... then an avalanche showing effectiveness vs hospitalisation, vs critical care, vs death, for subgroups, different variants, different vaccines, over time. These are UK only - knock yourself out.
That first study was just designed to check it worked safely vs cases.
www.gov.uk/guidance/mon...
That first study was just designed to check it worked safely vs cases.
www.gov.uk/guidance/mon...
Monitoring reports of the effectiveness of COVID-19 vaccination
Data on the real-world efficacy of the COVID-19 vaccines.
www.gov.uk
September 2, 2025 at 8:35 PM
A bizarre dogma has emerged among the anti-mRNA crowd that the only data we have on vaccines is from the original trial papers, rather than the HUGE volume of studies that came out subsequently...
Blood cultures - the next frontier in diagnostic stewardship? Anastasia Wasylyshyn from the Division contributing here.
journals.asm.org/doi/10.1128/...
journals.asm.org/doi/10.1128/...
Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardization | Journal of Clinical Microbiology
Blood culture contamination (BCC) is associated with patient harm and unnecessary
use of healthcare resources. BCC thresholds have been established; however, multiple
BCC definitions exist. There is l...
journals.asm.org
September 1, 2025 at 1:35 PM
Blood cultures - the next frontier in diagnostic stewardship? Anastasia Wasylyshyn from the Division contributing here.
journals.asm.org/doi/10.1128/...
journals.asm.org/doi/10.1128/...
New review on genomic epidemiology of C diff from Evan Snitkin in the Division.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Genomic Epidemiology of Clostridioides difficile
www.sciencedirect.com
September 1, 2025 at 12:39 PM
New review on genomic epidemiology of C diff from Evan Snitkin in the Division.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
New data on RSV VE from the CDC sponsored IVY network. This sort of work could be in jeopardy given events of the last several weeks.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons
This study investigates respiratory syncytial virus vaccine effectiveness against hospitalization among US adults aged 60 years or older during 2 seasons.
jamanetwork.com
September 1, 2025 at 12:38 PM
New data on RSV VE from the CDC sponsored IVY network. This sort of work could be in jeopardy given events of the last several weeks.
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
He’s not a therapy dog but I’m willing to bring my dog Wilmont to our noon conference 😂 @martenhawkins.bsky.social @lcahuaymemd.bsky.social
#idsky #wellness #idfellow #idfellowship #medwellness we have ‘Love on leash’ therapy dogs visit us after our noon conference (shout out to our fellowship coordinator, Elizabeth for arranging it!)
August 29, 2025 at 4:26 PM
He’s not a therapy dog but I’m willing to bring my dog Wilmont to our noon conference 😂 @martenhawkins.bsky.social @lcahuaymemd.bsky.social
The federal government has decided to severely limit access to vaccines that have been shown to reduce illness, hospitalization, and death. Whereas we used to argue about whether government was forcing you to be vaccinated, now we government saying you can’t get vaccinated.
The Food and Drug Administration on Wednesday approved updated Covid vaccines for the fall season that limit who can get the shots, the federal government’s most restrictive policy since the vaccines became available. Story by @by-cjewett.bsky.social and Jacey Fortin. Gift link: nyti.ms/3Hz1WhX
nyti.ms
August 27, 2025 at 5:32 PM
The federal government has decided to severely limit access to vaccines that have been shown to reduce illness, hospitalization, and death. Whereas we used to argue about whether government was forcing you to be vaccinated, now we government saying you can’t get vaccinated.
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study url: academic.oup.com/cid/article-...
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Among influenza patients hospitalized during the 2022–2023 influenza season, initiating treatment with oseltamivir on the day of admission (compared with l
academic.oup.com
August 27, 2025 at 9:23 AM
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study url: academic.oup.com/cid/article-...
Reposted by ID Chief @ UMich
open.substack.com/pub/clauswil... this is very true and highly under appreciated. Not just for a PhD but any high level accomplishment.
August 27, 2025 at 2:59 AM
open.substack.com/pub/clauswil... this is very true and highly under appreciated. Not just for a PhD but any high level accomplishment.
Reposted by ID Chief @ UMich
ID fellows: join IDSA Fellows Community of Practice & CPSolvers for a virtual Fellows Case Conference this Friday at 3PM ET! This session will include an interesting case presentation and small group discussion, featuring Daniel Minter, MD, and Varun Phadke, MD.
Register: https://bit.ly/47bJczm
Register: https://bit.ly/47bJczm
August 27, 2025 at 2:19 AM
ID fellows: join IDSA Fellows Community of Practice & CPSolvers for a virtual Fellows Case Conference this Friday at 3PM ET! This session will include an interesting case presentation and small group discussion, featuring Daniel Minter, MD, and Varun Phadke, MD.
Register: https://bit.ly/47bJczm
Register: https://bit.ly/47bJczm
New from Marisa Miceli in the Division!
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons Without HIV url: academic.oup.com/ofid/article...
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons Without HIV url: academic.oup.com/ofid/article...
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons Without HIV
AbstractBackground. Histoplasma urine antigen detection, a valuable diagnostic tool, is often used to monitor response to antifungal therapy, but persisten
academic.oup.com
August 25, 2025 at 1:05 PM
New from Marisa Miceli in the Division!
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons Without HIV url: academic.oup.com/ofid/article...
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons Without HIV url: academic.oup.com/ofid/article...
Reposted by ID Chief @ UMich
Take 5 minutes and watch this. Destroying biomedical research is dangerous, quite literally. www.nytimes.com/2025/08/24/o...
Opinion | America First? Not When It Comes to Your Health.
www.nytimes.com
August 24, 2025 at 7:39 PM
Take 5 minutes and watch this. Destroying biomedical research is dangerous, quite literally. www.nytimes.com/2025/08/24/o...
Friday emails of funding opportunities from the NIH used to take a little time to digest. They've gotten a lot easier lately, today's especially.
August 22, 2025 at 7:10 PM
Friday emails of funding opportunities from the NIH used to take a little time to digest. They've gotten a lot easier lately, today's especially.
Reposted by ID Chief @ UMich
California’s Valley Fever cases have jumped 1,200% in 25 years - from 1k to over 12.5k a year. Climate change, construction, agriculture - and perhaps increased familiarity and testing - are driving the surge.
www.sfgate.com/bayarea/arti...
www.sfgate.com/bayarea/arti...
'They're not going to live normally': A devastating disease has surged in Calif.
Cases are on pace to surpass last year's record-breaking levels.
www.sfgate.com
August 19, 2025 at 4:33 PM
California’s Valley Fever cases have jumped 1,200% in 25 years - from 1k to over 12.5k a year. Climate change, construction, agriculture - and perhaps increased familiarity and testing - are driving the surge.
www.sfgate.com/bayarea/arti...
www.sfgate.com/bayarea/arti...
Reposted by ID Chief @ UMich
one small consolation of being a 60+ year old investigator is the ability to submit to 𝘔𝘈𝘛𝘜𝘙𝘌 family journals — sure they’re low impact (for our knees) but they have an early bird special if you submit between 4:00 and 5:30 on weekdays
August 14, 2025 at 12:32 AM
one small consolation of being a 60+ year old investigator is the ability to submit to 𝘔𝘈𝘛𝘜𝘙𝘌 family journals — sure they’re low impact (for our knees) but they have an early bird special if you submit between 4:00 and 5:30 on weekdays
Novel oral polio vaccines, now in type 1 and type 3 “flavors”!
New Research:
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial
www.thelancet.com/journals/lan...
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial
www.thelancet.com/journals/lan...
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised contro...
nOPV1 and nOPV3 were well tolerated and showed similar immunogenicity and shedding
profiles to mOPV1 and mOPV3, respectively, supporting progression of these vaccine
candidates to phase 2 studies.
www.thelancet.com
August 14, 2025 at 10:53 AM
Novel oral polio vaccines, now in type 1 and type 3 “flavors”!
Reposted by ID Chief @ UMich
I share this in case you're very literal like me and wonder why people keep insisting it's because coronaviruses look like they have a crown, when they don't.
August 14, 2025 at 9:53 AM
I share this in case you're very literal like me and wonder why people keep insisting it's because coronaviruses look like they have a crown, when they don't.
Reposted by ID Chief @ UMich
April 7, 2025 at 10:21 AM
Not to mention what it would do to society journals.
NIH is considering changes in supporting publication costs--some ideas are quite radical and would endanger our ability to publish at all. I don't love the cots from the big for-profits but it does cost$ to run a journal. Please repost. Comment at:
osp.od.nih.gov/comment-form....
osp.od.nih.gov/comment-form....
August 12, 2025 at 2:06 AM
Not to mention what it would do to society journals.
Reposted by ID Chief @ UMich
On IDSA’s & HIVMA’s Science Speaks blog: Learn about JID’s latest monthly roundup of papers relevant to clinicians, including advancements in defining post-COVID conditions, therapeutic success of adjunctive carbapenems for MRSA and more. buff.ly/Qvbuhxj
JID for Clinicians: Advancements in defining post-COVID conditions, therapeutic success of adjunctive carbapenems for MRSA and more
Learn about the impact of HPV vaccination programs in Sweden, ceftriaxone-resistant N. gonorrhoeae strains in Vietnam and other research ready to inform clinical practice.
www.idsociety.org
August 12, 2025 at 12:03 AM
On IDSA’s & HIVMA’s Science Speaks blog: Learn about JID’s latest monthly roundup of papers relevant to clinicians, including advancements in defining post-COVID conditions, therapeutic success of adjunctive carbapenems for MRSA and more. buff.ly/Qvbuhxj
Nice work from Marisa Miceli in the Division.
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons without HIV
Marisa Miceli and colleagues
academic.oup.com/ofid/advance...
Marisa Miceli and colleagues
academic.oup.com/ofid/advance...
Lack of Association Between Histoplasma Urine Antigen Values and Clinical Response in Persons without HIV
AbstractBackground. Histoplasma urine antigen detection, a valuable diagnostic tool, is often used to monitor response to antifungal therapy, but persisten
academic.oup.com
July 29, 2025 at 6:46 PM
Nice work from Marisa Miceli in the Division.